Eli Lilly cut its annual earnings outlook for the second time, after it missed market estimates by a large margin in its second-quarter results, hit by lower insulin prices. It is recalled that the US House of Representatives approved in March a bill that limits the monthly participation for insulin for those with health insurance […]
Tag: Eli Lilly
Eli Lilly: Earnings and revenue better than expected in the quarter
Eli Lilly & Co’s share in pre-conference trading strengthened by 1.8%, as the pharmaceutical industry announced profits and revenues for the first quarter that exceeded estimates. Net income rose to $ 1.90 billion, or $ 2.10 a share, from $ 1.36 billion, or $ 1.49, a year earlier. Excluding extraordinary items, adjusted earnings per share […]
Regeneron – Eli Lilly: Antibody Therapies Against Omicron Less Effective
Early tests suggest that coronavirus antibody therapy developed by Regeneron Pharmaceuticals is losing its effectiveness against the Omicron variant, but the full impact will be known in the coming weeks after further studies, the president told the Wall Street Journal. Head of the Scientific Team of the company, George Yancopoulos. It is recalled that the […]